2-(4-((2-Methyl-3-oxo-3,5,7,8-tetrahydropyrido[4,3-c]pyridazin-6(2H)-yl)methyl)thiazol-2-yl)-N-phenylacetamide

Catalog No. :
ACQNOO436
CAS No. :
2093679-56-0
Molecular Formula :
C20H21N5O2S
Molecular Weight :
395.49

IUPAC Name:2-(4-((2-methyl-3-oxo-3,5,7,8-tetrahydropyrido[4,3-c]pyridazin-6(2H)-yl)methyl)thiazol-2-yl)-N-phenylacetamide

2-(4-((2-Methyl-3-oxo-3,5,7,8-tetrahydropyrido[4,3-c]pyridazin-6(2H)-yl)methyl)thiazol-2-yl)-N-phenylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-((2-Methyl-3-oxo-3,5,7,8-tetrahydropyrido[4,3-c]pyridazin-6(2H)-yl)methyl)thiazol-2-yl)-N-phenylacetamide
IUPAC Name2-(4-((2-methyl-3-oxo-3,5,7,8-tetrahydropyrido[4,3-c]pyridazin-6(2H)-yl)methyl)thiazol-2-yl)-N-phenylacetamide
Molecular FormulaC20H21N5O2S
Molecular Weight395.49
SMILESO=C(NC1=CC=CC=C1)CC2=NC(CN(C3)CCC(C3=C4)=NN(C)C4=O)=CS2
InChI KeyIGCQUCIHQDONOR-UHFFFAOYSA-N
CAS No.2093679-56-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQNOO436 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQNOO436 route product structure diagram
    ACQNOO4362093679-56-0
Inquiry

2. ACQNOO436 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQNOO436 route product structure diagram
    ACQNOO4362093679-56-0
Inquiry

Comments (0)